Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.40 Analyst target: $8.00 Upside: 233.33%
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.